We serve Chemical Name:methyl 2-bromo-3-(4-fluorophenyl)-3-oxopropanoate CAS:1001922-15-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl 2-bromo-3-(4-fluorophenyl)-3-oxopropanoate
CAS.NO:1001922-15-1
Synonyms:I01-8774;methyl 2-bromo-3-(4′-fluorophenyl)-3-oxopropanoate;2-bromo-3-(4-fluorophenyl)-3-oxopropionic acid methyl ester
Molecular Formula:C10H8BrFO3
Molecular Weight:275.07100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.37000
Exact Mass:273.96400
LogP:1.94490
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like I01-8774 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-3-(4-fluorophenyl)-3-oxopropionic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-3-(4-fluorophenyl)-3-oxopropionic acid methyl ester Use and application,I01-8774 technical grade,usp/ep/jp grade.
Related News: As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory��s officials as they are struggling to contain the coronavirus outbreak. methyl 2-bromo-3-(4-fluorophenyl)-3-oxopropanoate manufacturer ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. methyl 2-bromo-3-(4-fluorophenyl)-3-oxopropanoate supplier It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. methyl 2-bromo-3-(4-fluorophenyl)-3-oxopropanoate vendor As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory��s officials as they are struggling to contain the coronavirus outbreak. methyl 2-bromo-3-(4-fluorophenyl)-3-oxopropanoate factory In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.